Clinical Trials Logo
  1. Home
  2. Urinary Bladder Diseases
  3. NCT04914442
  4. Details
NCT04914442 Clinical Trial

Eosinophilic Cystitis Mimicking Urothelial Neoplasia

Urinary Bladder Diseases Clinical Trial

Official title:
Eosinophilic Cystitis Mimicking Urothelial Neoplasia: A Retrospective Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04914442
Other study ID # AUH210501
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 17, 2017
Est. completion date January 20, 2021

Study information
Verified date June 2021
Source Al-Azhar University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

We explored the potential etiology, clinical and histopathology presentation of the eosinophilic cystitis cases, clinically mimicking urothelial neoplasia. Surgical procedure and clinical outcome also evaluated. T

Description:

A pooled 22 patients diagnosed with eosinophilic cystitis on microscopic examination in our hospital during four years were retrospectively studied.We explored the potential etiology, clinical and histopathology presentation of the eosinophilic cystitis cases, clinically mimicking urothelial neoplasia. Surgical procedure and clinical outcome also evaluated. Transurethral resection of the lesions were performed and pathologically examined, we re-examined the studied cases and made a clinical correlation.

Recruitment information / eligibility
Status Completed
Enrollment 22
Est. completion date January 20, 2021
Est. primary completion date January 15, 2021
Accepts healthy volunteers
Gender All
Age group 10 Years to 90 Years
Eligibility Inclusion Criteria: - Clinically suspected urothelial neoplasia Exclusion Criteria: - Patients who did not complete the follow up period

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Microscopic examination
All the studies cases are microscopically examined using the ordinary stains (hematoxylin and eosin) then the eosinophilic infiltration are counted in 10 high power field manually

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Al-Azhar University

Outcome
Type Measure Description Time frame Safety issue
Primary Eosinophil cell count Each tissue slide is retrieved and examined to count the eosinphils in the submucosa, positive cases revelaed more than 90% eosinophils of the whole inflammatory cells 1 day
See also
  Status Clinical Trial Phase
Completed NCT02320773 - A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Completed NCT03081858 - Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer Phase 1/Phase 2
Recruiting NCT05250908 - INTIBIA Pivotal Study N/A
Completed NCT01340027 - A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder Phase 2
Recruiting NCT04922047 - Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) Phase 1/Phase 2
Completed NCT01638000 - A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. Phase 3
Completed NCT04161716 - Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH) N/A
Completed NCT01908829 - A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) Phase 3
Recruiting NCT04442724 - Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy N/A
Completed NCT02386072 - A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Completed NCT02891460 - Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients N/A
Terminated NCT00384891 - Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer Phase 3
Recruiting NCT06237920 - Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab Phase 2
Completed NCT03845725 - Falls and Balance of Patients With Parkinson's Disease With Urinary Disturbance
Completed NCT02307487 - Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients Phase 2
Recruiting NCT05153694 - Infectious Complications After Cystectomy: A Prospective Observational Study
Completed NCT01930799 - Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns Phase 4
Terminated NCT01060254 - A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain Phase 2
Not yet recruiting NCT05643963 - The COOKER-BLADDER Trial N/A
Active, not recruiting NCT03245242 - Pediatric Urology Recovery After Surgery Endeavor (PURSUE)